小鼠B淋巴細胞雜交瘤細胞；SH3
ScienCell研究實驗室（ScienCell http://www.shijichina.com/goodsid/fenleiyi/3205368_sciencell/1.html）是一家生物技術公司綜合運用，主要提供實驗和治療使用細胞和細胞相關產品。

小鼠B淋巴細胞雜交瘤細胞的方法；SH3

ScienCell研究實驗室（ScienCell /goodsid/fenleiyi/3205368_sciencell/1.html）是一家生物技術公司體系，主要提供實驗和治療使用細胞和細胞相關產品，多種高品質正常的人類和動物細胞帶動產業發展，細胞培養(yǎng)基和試劑責任製，培養(yǎng)基補充，細胞來源的RNA倍增效應，基因和蛋白質等規則製定。總部設在加利福尼亞州圣迭戈優化服務策略，成立于1999年關規定。細胞培養(yǎng) / ScienCell Research Laboratories (ScienCell) is a biotechnology company whose mission is the research and development of cell and cell-related products for experimental and therapeutic use. The ScienCell technology provides a variety of high quality normal human and animal cells, cell culture media and reagents, medium supplements, cell-derived RNA, cDNA and proteins for the research community. Scientists at ScienCell are also studying and developing cell therapeutic strategies that will significantly improve the quality of life by achieving the cell's ability to combat human degenerative disorders. We are based in San Diego, California and were established in 1999.atcc /

小鼠B淋巴細胞雜交瘤細胞；SH3

ScienCell / Research Laboratories is an expanding biotechnology company whose mission is the research and development of cell and cell-related products for experimental and therapeutic use. The ScienCell technology provides a variety of high quality normal human and animal cells, cell culture media and reagents, cell growth supplements, cell-derived DNA, RNA, and proteins, cell-based assay kits, and stem cell products for the research community. To complement our vast array of primary cells, we offer specialty medium designed to selectively promote unique cell growth, including STEMium™, which allows for the optimal growth of human pluripotent stem cells under feeder-free condition. Scientists at ScienCell are also studying and developing cell therapeutic strategies that will significantly improve the quality of life by utilizing the cell's ability to combat human degenerative disorders. We are based in San Diego, California and established in 1999.